Management of bone loss due to endocrine therapy during cancer treatment. Khan MI. Osteoporos Int 2023 Jan 19. doi: 10.1007/s00198-023-06672.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Khan MI. Management of bone loss due to endocrine therapy during cancer treatment. Osteoporos Int 2023 Jan 19. doi: 10.1007/s00198-023-06672.
PMID: 36656338